Literature DB >> 498587

Purification of soluble immune complexes from serum using polymethylmetacrylate beads coated with conglutinin or C1q. Application to the analysis of the components of in vitro formed immune complexes and of immune complexes occurring in vivo during leishmaniasis.

P Casali, P H Lambert.   

Abstract

A procedure for the isolation of immune complexes from human sera has been developed. Two steps are involved: (1) lipid-free serum is precipitated by polyethylene glycol; (2) the solubilized precipitate is absorbed on a column of polymethylmethacrylate beads coated with conglutinin (K) or C1q; the column is washed, the complexes are then eluted, using 0.02 M EDTA (for K column) or 0.5 M NaCl (for C1q column). This procedure permitted the purification and the characterization of soluble 125I-BSA-anti-BSA, 125 I-tetanus toxoid-anti-tetanus toxoid, and 125-I-HBsAg-anti-HBsAg complexes made in vitro in the presence of fresh human serum. The isolated complexes were shown to contain antigen, antibody, C1q, C1r, C1s and C3. When normal human serum was submitted to such a procedure, no detectable amount of protein was present in the final eluted fraction. Immune complexes formed in vivo were also purified by conglutinin column from the serum of a patient with disseminated leishmaniasis. The isolated material was found to contain IgM, IgG, C1q, C1r, C1s, C3c and C3d. The purified complexes dissociated at acid pH were found to contain anti-IgG and anti-leishmania antibodies.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 498587      PMCID: PMC1537812     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

Review 1.  THE ROLE OF ANTIGEN-ANTIBODY COMPLEXES IN DISEASE.

Authors:  F J DIXON
Journal:  Harvey Lect       Date:  1963

2.  A method for determining the sedimentation behavior of enzymes: application to protein mixtures.

Authors:  R G MARTIN; B N AMES
Journal:  J Biol Chem       Date:  1961-05       Impact factor: 5.157

3.  Isolation of soluble immune complexes by affinity chromatography using staphylococcal protein A--Sepharose as substrate.

Authors:  F Chenais; G Virella; C C Patrick; H H Fudenberg
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

4.  The nature of immune complexes in human cancer sera.

Authors:  A N Theofilopoulos; B S Andrews; M M Urist; D L Morton; F J Dixon
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

5.  Solid-phase enzyme immunoassay or radioimmunoassay for the detection of immune complexes based on their recognition by conglutinin: conglutinin-binding test. A comparative study with 125I-labelled Clq binding and Raji-cell RIA tests.

Authors:  P Casali; A Bossus; N A Carpentier; P H Lambert
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

6.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

7.  Rabbit C1q: purification, functional and structural studies.

Authors:  J E Volanakis; R M Stroud
Journal:  J Immunol Methods       Date:  1972-11       Impact factor: 2.303

Review 8.  Mechanism of solubilization of immune aggregates by complement. Implications for immunopathology.

Authors:  M Takahashi; J Czop; A Ferreira; V Nussenzweig
Journal:  Transplant Rev       Date:  1976

9.  Isolation of circulating immune complexes using Raji cells. Separation of antigens from immune complexes and production of antiserum.

Authors:  A N Theofilopoulos; R A Eisenberg; F J Dixon
Journal:  J Clin Invest       Date:  1978-06       Impact factor: 14.808

10.  Evidence that bovine conglutinin reacts with an early product of C3b degradation, and an improved conglutination assay.

Authors:  W D Linscott; R Ranken; R P Triglia
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

View more
  30 in total

1.  Immune complex glomerulonephritis in experimental kala-azar. II: Detection and characterization of parasite antigens and antibodies eluted from kidneys of Leishmania donovani-infected hamsters.

Authors:  A Sartori; M C Roque-Barreira; J Coe; A Campos-Neto
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

2.  Dissociation of IgG antibody-mediated clumps of Trypanosoma brucei gambiense by complement.

Authors:  T Takayanagi; H Kawaguchi; Y Yabu; M Itoh; K Yano
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

3.  Electrophoretic transfer blotting analysis of immune complexes in rheumatoid arthritis.

Authors:  R D Inman; N C Hamilton; P B Redecha; D M Hochhauser
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

4.  Persistence of elevated levels of galactosyl-alpha(1-3)galactose antibodies in sera from patients cured of visceral leishmaniasis.

Authors:  J L Avila; M Rojas; L García
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

5.  Specific hemoperfusion through agarose acrobeads.

Authors:  S Margel; L Marcus
Journal:  Appl Biochem Biotechnol       Date:  1986-02       Impact factor: 2.926

6.  Clearance kinetics and organ uptake of complement-solubilized immune complexes in mice.

Authors:  M T Aguado; M Mannik
Journal:  Immunology       Date:  1987-02       Impact factor: 7.397

7.  Polyclonal B cell activation, circulating immune complexes and autoimmunity in human american visceral leishmaniasis.

Authors:  B Galvão-Castro; J A Sá Ferreira; K F Marzochi; M C Marzochi; S G Coutinho; P H Lambert
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

8.  Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies.

Authors:  G Valesini; M Picardo; R Pastore; P Pivetti; U Serafini
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

9.  Identification of leishmanial antigens in the sera of patients with American visceral leishmaniasis.

Authors:  T G Evans; R D Pearson
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

10.  Immune complexes in Hodgkin's disease: isolation, immunochemical and physico-chemical analysis.

Authors:  W Kilgallon; P L Amlot; B D Williams
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.